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Disorders of the timing of parturition are the most important complications of modern obstetrics. Although preterm delivery occurs in 6-7% of all births, these preterm infants account for approximately 75% of the mortality and long term morbidity associated with the birthing process. The costs, both financial and emotional, are tremendous. In contrast to most areas of obstetrics, little progress has been made over the past few decades in the prevention or treatment of preterm labour. This is due largely to our poor understanding of the mechanisms underlying regulation of myometrial contractility, either in physiological or pathophysiological situations. For many decades, oxytocin has been implicated in the process of parturition but there remains great controversy about its role. This review will address this controversy with particular reference to research data from the past decade. For the sake of brevity, the review will emphasize human data supplemented by experimental data from rat models of parturition. Although there are relatively few data from human studies, it appears that the trends in concentrations during late gestation and the regulation of oxytocin and its receptor may be very similar to those of rats. At least from this narrow perspective, it appears that the rat may be a suitable and relevant experimental model.
Historical perspective
Almost a century ago, Dale (1906) noted the ability of posterior pituitary extract to stimulate uterine contractility. Blair Bell (1909) used this extract to treat postpartum haemorrhage due to uterine atony. The active factor was called oxytocin because of its potent contractile activity in the pregnant uterus (from the Greek oxus, meaning sharp and tokos, referring to childbirth). By the 1940s, oxytocin was introduced into clinical practice to stimulate labour (Theobold et al., 1948) as well as to treat postpartum haemorrhage. The oxytocin molecule was biochemically characterized by Du Vigneaud et al. in 1953 and the gene was cloned 30 years later (Land et al., 1983) . Until the last decade, most investigators considered that oxytocin was an endocrine hormone synthesized in the supraoptic and paraventricular nuclei of the hypothalamus, transported along axons to and stored in secretory granules in the posterior pituitary, and then released into the circulation to cause contraction of the myometrium during pregnancy or milk letdown during lactation.
Several lines of evidence support an important role for oxytocin in the initiation of parturition. First, oxytocin is the commonest agent used to stimulate uterine contractions in pregnant women during late gestation. The labour pattern induced by oxytocin is indistinguishable from normal spontaneous labour. Second, in several species, including humans, maternal plasma oxytocin concentrations are many-fold higher during labour than in late pregnancy before labour (reviewed in Hirst et al., 1993) . Third, recent evidence in rats (Chan et al., 1991; Fejgin et al., 1994; Antonijevic et al., 1995) , non-human primates (Honnebier et al., 1989; Wilson et al., 1990; Hirst et al., 1991) and humans (Akerlund et al., 1987; Goodwin et al., 1994) demonstrates that oxytocin antagonists can inhibit late gestational uterine contractions and may interfere with the process of parturition. Finally, the number of oxytocin receptors in the pregnant uterus increases markedly at the time of parturition in humans (Fuchs et al., 1982) and rats (Soloff at al., 1979; Fang et al., 1996) .
Oxytocin as an endocrine hormone in parturition
With demonstration of the potent, specific and physiological uterine contractile properties of oxytocin, many investigators attempted to establish oxytocin as the major factor in the initiation of labour. However, most of the results failed to support such a The role of oxytocin in parturition is controversial. When considered as an endocrine hormone, the balance of evidence suggests that oxytocin has little involvement in the initiation of labour. However, recent research has demonstrated synthesis of mRNA encoding oxytocin within the pregnant human uterus. This article reviews the hypothesis that oxytocin is an important paracrine (or autocrine) hormone with respect to the control of myometrial contractility in late gestation. Experimental data are provided from humans when possible and from studies using the rat as an experimental model. The processing of oxytocin prohormones in uterine tissues is reviewed and the presence and possible role of carboxy-extended forms of oxytocin in late gestational tissues of rats are discussed. The regulation of oxytocin and its receptor, particularly by oestrogen and progesterone, is reviewed. The inter-relationship between oxytocin and prostaglandins is discussed. Finally, the metabolism of oxytocin within intrauterine tissues and the recent development of specific antagonistic analogues to oxytocin are considered. It is concluded that further clarification of this paracrine system within intrauterine tissues during late gestation could lead to more successful strategies for preventing or arresting preterm labour in women.
hypothesis and suggested that the importance of oxytocin was confined to the expulsive stage of labour and for involution of the uterus. Most, but not all, investigators reported that serum oxytocin concentrations are very low in nonpregnant women and remain low throughout pregnancy. Indeed, Thornton et al. (1992) found that approximately 70% of samples obtained during early labour in women contained undetectable concentrations of oxytocin despite using an assay with sensitivity to 1.4 pmol l -1 . Most investigators could not measure an increase in maternal serum oxytocin concentrations until well after the onset of labour (reviewed in Chard, 1989; Hirst et al., 1993) . Peak concentrations occur at the time of fetal expulsion (Fitzpatrick, 1961; Dawood et al., 1978) . Furthermore, the association constant of the oxytocin receptor is of the order of 1-2 nmol l -1 (Soloff, 1975 ), yet maximal uterine activity occurs when serum oxytocin concentrations are in the range 10-100 pmol l -1 . Finally, women with known posterior pituitary dysfunction have apparently normal labours (Chard, 1989) . Thus, despite the compelling theoretical support for an important role for oxytocin in the initiation of parturition, the experimental evidence was very controversial.
Some of the controversy may have resulted from technical difficulties in measuring serum oxytocin concentrations at the time of parturition. The difficulties include low hormone concentrations and the presence in late human pregnancy serum of an oxytocinase that rapidly degrades oxytocin after sample collection (Page, 1946) . Furthermore, even using very precise radioimmunoassays, there is marked variability in plasma oxytocin concentrations compatible with a pulsatile secretion into the circulation (Gibbens and Chard, 1976; Fuchs et al., 1991) . The plasma half-life of oxytocin is of the order of a few minutes (Thornton et al., 1990) , which means that pulses with significant amplitude may be of short duration. This necessitates frequent sampling to ensure that pulses are not missed. Furthermore, it is now recognized that some antibodies used to measure oxytocin may give artificially high measurements due to crossreactivity with oxytocin precursors (Amico and Hempel, 1990) that are probably devoid of biological activity (see below). However, even with a sensitive and specific radioimmunoassay, the use of oxytocinase inhibitors and a 1 min sampling frequency protocol, some investigators did not detect a significant increase in maternal plasma oxytocin concentrations until the second stage (fetal expulsion) or third stage (placental expulsion) of labour (Thornton et al., 1992) . Conversely, others noted an increase in oxytocin concentrations or in oxytocin pulse frequency at the beginning of labour (Dawood et al., 1978; Otsuki et al., 1983; Fuchs et al., 1991) .
Human fetuses are known to synthesize oxytocin in late pregnancy (Chard et al., 1971) . Several investigators have considered a role for fetal oxytocin in the initiation of parturition (for review see Chard, 1989) . In summary, the human fetal pituitary contains oxytocin in increasing concentrations from 14 weeks of gestation onwards (Khan-Dawood and Dawood, 1984) . Concentrations of oxytocin are higher in umbilical serum than in maternal serum and are higher in the umbilical arterial than in the venous circulation. However, normal parturition often occurs in cases of fetal anencephaly in the absence of fetal oxytocin synthesis (Otsuki et al., 1983) . The general concensus among investigators is that fetal oxytocin is unlikely to play a role in regulating the timing of human parturition.
There are few data concerning oxytocin concentrations in rat maternal serum in late gestation. As in humans, there are several technical problems in measuring serum oxytocin in rats but the results appear similar. Using intrauterine balloons to detect the onset of uterine contractions precisely, Higuchi et al. (1985 Higuchi et al. ( , 1986 noted no increase in oxytocin concentrations until the expulsive phase of labour. The highest concentrations of oxytocin were noted during milk ejection.
Thus, before 1992, the majority of evidence regarding maternal or fetal serum oxytocin concentrations favoured rejection of a major role for oxytocin in the physiological onset of labour. Most investigators concluded that the role of oxytocin in labour was, at most, facilitatory and that the hormone had perhaps a more important role in the prevention of postpartum haemorrhage and for milk letdown during lactation. However, a closer review of the literature coupled with more recent findings have rekindled the debate. Physiological parturition at term is preceded by nocturnal increases in uterine contractions in several species, including rhesus monkeys (Ducsay et al., 1983; Honnebier et al., 1989) and humans (Zahn, 1984; Seron-Ferre et al., 1991) . These nocturnal contractions correlate closely with oxytocin concentrations of maternal serum in both rhesus monkeys (Honnebier et al., 1989; Hirst et al., 1991; Seron-Ferre et al., 1991) and humans (Fuchs et al., 1992) . The nocturnal surges of uterine activity near term can be ablated in rhesus monkeys (Honnebier et al., 1989; Hirst et al., 1991) by the use of specific oxytocin antagonists. Thus, the debate continues as to whether oxytocin is a relatively unimportant factor or a pivotal hormone in the mechanism of initiation of parturition.
Oxytocin as a paracrine hormone
Some of the controversial aspects of the role of oxytocin in parturition may be rationalized by recent research demonstrating expression of the oxytocin gene in peripheral tissues, which suggests a paracrine or autocrine role rather than, or in addition to, an endocrine role for oxytocin in parturition. If the principal actions of oxytocin are in a paracrine system, important changes may occur without reflection in the maternal circulation. This fact may modify conclusions regarding the role of oxytocin in parturition that were made on the basis of assessment of oxytocin solely as an endocrine factor.
The first suggestion that oxytocin synthesis occurs in peripheral tissues was made after measurement of high oxytocin concentrations in ovine corpus luteal tissues (Wathes and Swann, 1982) . Synthesis of mRNA encoding oxytocin in luteal tissue was demonstrated subsequently (Ivell and Richter, 1984) and further investigations uncovered an endocrine system involving ovarian oxytocin and uterine prostaglandin F 2α in regulation of ovine luteolysis (Flint and Sheldrick, 1983) . Chibbar et al. (1993) then demonstrated mRNA encoding oxytocin in human intrauterine tissues in late gestation, principally in the decidua but also in the chorion and amnion. They also measured significantly greater concentrations of mRNA encoding oxytocin in tissues obtained after the onset of spontaneous labour at term in comparison with tissues obtained at term but before the onset of labour. This difference suggested that the synthesis of mRNA encoding oxytocin increased around the time of onset of parturition. In humans, tissue concentrations of oxytocin are low and technically difficult to measure owing to the factors mentioned above with respect to serum oxytocin, and no good data are presently available. However, the concept of regulation of oxytocin synthesis in a paracrine system within the pregnant uterus could rationalize many of the controversial findings regarding the role of oxytocin in the initiation of human parturition.
Several studies in rats have demonstrated a similar pattern of increased synthesis of mRNA encoding oxytocin and oxytocin in intrauterine tissues in late gestation. In this experimental model, tissue concentrations of mRNA encoding oxytocin and peptide appear to be several-fold higher than in humans. Lefebvre et al. (1992a Lefebvre et al. ( , 1993 showed increased synthesis of oxytocin in rat endometrial epithelial cells and in amnion cells before parturition. These investigators estimated that the total mRNA encoding oxytocin in the intrauterine tissues was approximately 70-fold higher than in the neurohypophysis. They also noted synthesis of mRNA encoding oxytocin in the rat placenta but concentrations decreased in late gestation (Lefebvre et al., 1992b) . Subsequent investigations in rats revealed that concentrations of mRNA encoding oxytocin were highest by day 18 of gestation but that oxytocin concentrations did not increase significantly until the morning of day 22, which is the day of parturition in this species (Fang et al., 1996) . These findings suggest the importance of translation, in addition to transcription, from the oxytocin gene as a potentially important regulatory step in the process of parturition.
The markedly increasing concentrations of mRNA encoding oxytocin and oxytocin in late gestational intrauterine tissues, and the intimate anatomical proximity of these tissues to the presumed target tissues -the endometrium and myometriumlend strong support to the hypothesis of an intrauterine paracrine system that regulates the timing of parturition.
Oxytocin receptors
One of the most consistent findings in the study of parturition in several species is the increase in oxytocin receptors before the onset of labour. The late gestational increase in oxytocin binding in the uterus was first described in rats (Soloff et al., 1979) and subsequently demonstrated in humans (Fuchs et al., 1982) . The increased oxytocin binding correlates with the increased uterine sensitivity to exogenously administered oxytocin in both humans (Caldeyro-Barcia and Serono, 1959; Theobold et al., 1969) and rats (Fuchs et al., 1983) . In both species, oxytocin receptors are present in the endometrium as well as in the myometrium (Chan, 1980; Fuchs et al., 1982) . On the basis of studies using different oxytocin antagonists, Chan (1980) postulated the presence of two distinct subtypes of oxytocin receptors but, to date, there has been no evidence supporting the existence of more than one oxytocin receptor gene or transcript.
The oxytocin receptor is a classical membrane receptor with seven transmembrane domains linked through a G protein complex to a phospholipase C-protein kinase C signal transduction system (Phaneuf et al., 1993;  Fig. 1 ). The coupling proteins include α q and α 11 subunits. Within seconds of oxytocin stimulation, there are markedly higher intracellular concentrations of inositol trisphosphate and Ca 2+ . The higher Ca 2+ and calmodulin increase the myosin light chain kinase, which catalyses the contraction response.
The oxytocin receptor gene was first cloned from a library from pregnant human myometrium expressed in a Xenopus oocyte (Kimura et al., 1992) . Subsequently, the oxytocin receptor of several species, including rats (Inoue et al., 1994; Rozen et al., 1995; Kimura et al., 1996) , was cloned and characterized. In general, there is much similarity between species. The promoter regions also contain similar types of recognizable response elements. There are no palindromic oestrogen response elements in the first 3500 nucleotides upstream of the transcription start site but there are several copies of the 5'-or 3'-half response elements in the proximal promoter region. It is possible that these half response elements confer oestrogen responsivity, as is the case with the chicken ovalbumin gene (Tora et al., 1988) . There are no progesterone response elements. The presence of AP-1 sites suggest potential regulation by fos-jun heterodimers. Several response elements that may mediate responses from inflammatory cytokines, such as tumour necrosis factor, interleukin 1 and interleukin 6, are present in the oxytocin receptor promoter. The concentrations of these cytokines in human amniotic fluid are increased at the time of parturition both in pregnancies complicated by infection and in normal term or preterm labour in the absence of clinical evidence of infection (for review see Dudley and Trautman, 1994) . It is possible that the timing of human parturition is regulated to a large extent by the influence of the immune system on the oxytocin receptor gene, not only in cases associated with intrauterine infection but also in the normal physiological process.
Interactions between oxytocin and prostaglandins
Oxytocin stimulation of the myometrial oxytocin receptors leads to an immediate influx of Ca 2+ into the myocyte cytoplasm from both extracellular and intracellular sites (Phaneuf et al., 1993) resulting in a contractile response. However, oxytocin may also stimulate rat endometrial (Chan, 1980) or human decidual cells (Fuchs et al., 1981; Pasetto et al., 1988; Wilson et al., 1988) to produce prostaglandins which themselves may be uterotonic. Furthermore, other studies (Alexandrova and Soloff, 1980; Chan et al., 1988 ) using the rat model strongly suggest that prostaglandins are important stimulants of oxytocin receptor synthesis. In accordance, the late gestation increase in oxytocin receptors can be blocked by prostaglandin synthesis inhibitors (Chan et al., 1988) . Therefore, it is possible that there is a positive feedback system between oxytocin receptors and prostaglandins within the pregnant uterus that increases myometrial contractility at the time of parturition (Fig. 2) . In our studies using the progesterone antagonist RU486 to induce preterm labour at day 15 of rat gestation, the increase in oxytocin receptors occurred before the increase in prostaglandins (Fang et al., 1997) . These results suggest that, at least in this pharmacological model, oxytocin receptors are the primary drivers of this positive feedback loop.
Effects of sex steroids on oxytocin and oxytocin receptors
Although there are few data regarding the regulation of intrauterine oxytocin and oxytocin receptor gene expression, it appears that oestrogen and progesterone are important regulators. In both rats and humans (Land et al., 1983; reviewed in Zingg et al., 1995) , the oxytocin gene contains an imperfect palindromic oestrogen response element and two additional half response elements that confer oestrogen sensitivity in transfected cells (Richard and Zingg, 1990) . High concentrations of plasma oxytocin have been correlated with high concentrations of oestradiol in humans (Amico et al., 1981) and rats (Yamaguchi et al., 1979) , and oestrogen treatment can increase plasma oxytocin concentrations in women (Amico et al., 1981) . Ovariectomy in rats decreases oxytocin gene expression in the hypothalamus (Burbach et al., 1990) ; but in these latter studies, replacement of oestradiol after ovariectomy did not increase neural oxytocin gene expression, suggesting that ovarian factors in addition to oestrogen are important. We have observed that oestradiol significantly increases mRNA encoding oxytocin in pre-pubescent rats and that this effect can also be obtained using aromatizable androgen but not using the nonaromatizable dihydrotestosterone (Chibbar et al., 1990) . We have also demonstrated an oestrogen-stimulated increase in mRNA encoding oxytocin and in oxytocin in late gestational human amnion-chorion-decidua tissues using an in vitro explant system (Chibbar et al., 1995) .
The role of progesterone is less clear. As with oxytocin receptor, the promoter of the oxytocin gene has no progesterone responsive elements, suggesting that the effects of progesterone are indirect or non-genomic. In experiments using explants of human amnion-chorion-decidua, we showed a variable effect of progesterone: in most experiments, it appeared to have little or no effect and, in some, it appeared to block the oestrogeninduced increase in mRNA encoding oxytocin (Chibbar et al., 1995) . Inhibitory effects of progesterone may be mediated by suppression of oestrogen-induced oestrogen receptors, which has been demonstrated in the rat uterus (Bhakoo and Katzenellenbogen, 1977) and hamster decidua (Leavitt and Takeda, 1986) . Conversely, in non-pregnant rats, progesterone increases uterine synthesis of mRNA encoding oxytocin (Lefebvre et al., 1994) and, in late pregnant rats, the progesterone receptor antagonist RU486 causes a reduction in uterine mRNA encoding oxytocin (Fang et al., 1997) .
The evidence for sex steroid regulation of oxytocin receptors is considerably better. Soloff and coworkers (1975) demonstrated that oestrogen increases the number of oxytocin receptors in the rat uterus and that this can be blocked by concurrent administration of progesterone. Similar results have been obtained using rat uterine explants (Soloff et al., 1983) and in human myometrial cells in primary culture (Adachi and Masataka, 1995). Signal transduction mechanism for the oxytocin receptor in the myometrium. This receptor is a classic 7-transmembrane domain receptor linked through a G protein to phospholipase C. After receptor stimulation with oxytocin (OT), the α-subunit of the heterotrimeric G protein hydrolyses GTP to GDP and releases the βγ-subunit to stimulate phospholipase C. This enzyme converts phosphatidyl inositides to diacylglycerol and inositol-1,4,5-trisphosphate (IP 3 ). Diacylglycerol stimulates protein kinase C activity causing phosphorylation of substrates which will characterize the response of the specific cell type. The IP 3 stimulates flux of Ca 2+ into the cytoplasm through calcium channels, principally from the sarcoplasmic reticulum but also from the extracellular space. The increased Ca 2+ will combine with calmodulin to stimulate myosin light chain kinase (MLCK) to produce myometrial contraction. In the decidua, a characteristic response would be synthesis and release of prostaglandins.
Our experiments to explore paracrine relationships in pharmacological models of preterm and post-term labour in rats have provided interesting results regarding the role of sex steroids in regulation of oxytocin and oxytocin receptors (Table 1) . After administering the oestrogen receptor antagonist tamoxifen, rat parturition (normally on day 22) is significantly delayed by approximately 24 h (Fang et al., 1996) . Concentrations of mRNA encoding oxytocin and oxytocin are significantly decreased and remain low even at the time of the delayed parturition. Oxytocin receptor concentrations are also very low at the time of normal parturition but do increase to normal parturient concentrations before the time of the delayed labour, despite continued administration of the oestrogen antagonist. Similarly, there is a delay in the normal increase in uterine prostaglandin concentrations. When the progesterone receptor antagonist RU486 is administered as a single injection on day 15 (Fang et al, 1997) , mRNA encoding oxytocin receptors is increased by 6 h, the concentration of oxytocin receptors is significantly increased by 12 h, prostaglandin F 2α is increased by 24 h, and parturition of premature pups occurs at a mean of 27 h after injection. Concentrations of mRNA encoding oxytocin and oxytocin are decreased slightly and remain low.
Collectively, these data indicate that high concentrations of oxytocin are not required for parturition. This is in keeping with recent reports of normal parturition occurring in mice in which the oxytocin gene has been inactivated by homologous recombination of mutant genes in embyonic stem cells (Nishimori et al., 1996; Young et al., 1996) . Our data also suggest that oestrogen is not required for the pre-parturition increase in oxytocin receptors that occurred in the animals treated with tamoxifen. We suggest that the interaction between the oxytocin receptor and prostaglandins becomes the dominant mechanism in the absence of oestrogen. This contention is compatible with recent experiments in a prostaglandin F 2α receptor gene 'knockout' mouse, which appears normal in all respects but does not undergo parturition (Sugimoto et al., 1997) . In this model, oxytocin receptor concentrations remain undetectable and the uterus is unresponsive to oxytocin. Parturition can be induced only by oophorectomy, presumably secondary to the decline in progesterone consequent to oophorectomy.
Although this evidence supports the concept that oxytocin is not essential for parturition, it does not rule out an important role for oxytocin receptors. In all animal models of normal, preterm or delayed parturition in which oxytocin receptor concentrations have been measured, these concentrations have increased markedly before delivery. It is possible that there is an alternative, unknown ligand for the receptor or that this cell surface protein can stimulate uterine activity in the absence of ligand binding.
Studies in the human nonpregnant uterus have given more confusing results. Myometrial oxytocin receptor concentrations were lowest in menopausal women (very low oestrogen concentrations) and in cyclic women at mid-cycle (high oestrogen concentrations) (Maggi et al., 1992) . There was no correlation with urinary oestrogen concentrations. The highest concentrations were found in the late luteal phase and were positively correlated with urinary progesterone metabolite concentrations, suggesting that progesterone in this situation does not suppress myometrial oxytocin receptor concentrations. This finding indicates that regulation of human oxytocin receptors is different from the rat model, or perhaps, that there is a paracrine system in humans in which oestrogen and progesterone concentrations are not reflected in serum or urinary measurements.
In summary, although inconsistencies in the data remain, it appears that oestrogen and progesterone are the major regulators of intrauterine oxytocin and its receptor (Fig. 2) . Progesterone appears to have a positive effect on oxytocin but a strongly negative effect on oxytocin receptors, whereas oestrogen appears to upregulate both. In view of the absence of consensus response elements in the promoter regions of either gene, it is quite possible that all regulatory effects of the sex steroids are Fig. 2 . The hypothesized positive feedback loop between oxytocin receptor (OTR) and prostaglandins (PG) in the decidua and myometrium. Oxytocin (OT) is synthesized locally within the decidua and stimulates oxytocin receptors in both decidua and myometrium. The decidual response is to produce prostaglandins, principally PGF 2α , which, in turn, will increase synthesis of oxytocin receptors in myometrium. Oxytocin synthesis is stimulated by both oestrogen and progesterone. Oxytocin receptor synthesis is stimulated by oestrogen and possibly by inflammatory cytokines but is strongly suppressed by progesterone. indirect and involve other molecular mediators genomically or non-genomically. The recent cloning of the oxytocin receptor gene in several species shows many response elements to inflammatory cytokines, suggesting that these immunomodulators have an important role in the process of parturition (Inoue et al., 1994; Rozen et al., 1995; Kimura et al., 1996) . Further investigations into the nature and roles of these mediators may provide useful information towards the goal of controlling uterine activity. Page (1946) first documented that serum from pregnant women had the ability to metabolise oxytocin. Hooper and Jessup (1959) demonstrated the presence of this 'oxytocinase' activity predominantly in placental cytosol. Page (1946) also concluded that the activity was distinct from vasopressinase, which had a different subcellular localization. The clearance of oxytocin from human plasma during pregnancy has been studied by Thornton et al. (1990) . The metabolic clearance rate increases more than fourfold through pregnancy and is independent of plasma oxytocin concentrations, but is probably dependent on plasma oxytocinase activity, which is known to increase progressively through pregnancy (Mizutani and Tomoda, 1992) . Although abnormalities in serum oxytocinase have been suggested in the mechanisms of preterm parturition and pre-eclampsia (Tsujimoto et al., 1992) , these hypotheses remain unproven. The oxytocin molecule is a nonapeptide with a disulfide bridge between the cystines at positions 1 and 6 resulting in a ring structure at the N-terminus that is essential for biological activity (Fig. 3) . A common form of degradation is by aminopeptidase activity, which opens this ring (thus destroying biological activity) and cleaves the tyrosine at position 2 (Burbach and Lebouille, 1982) . A second method of catabolism occurs by the action of post-proline endopeptidase, which cleaves between the proline and leucine, thus splitting the terminal leucineglycine amide dipeptide from the molecule. Other possible methods of oxytocin breakdown could occur by the action of a carboxypeptidase cleaving amino acids from the C-terminus or by enzymatic disruption of the disulfide bond. Neither of these last mentioned pathways appear to be major methods of oxytocin metabolism.
Metabolism of oxytocin
We have studied oxytocinase activity in intrauterine tissues of humans and rats (Mitchell and Wong, 1996; Mitchell et al., 1997) . Our hypothesis was that catabolism of oxytocin produced within these tissues would decrease before parturition and result in a significant increase in local tissue oxytocin concentrations. We demonstrated that oxytocin is actively metabolised by the human chorion and decidua to an extent similar to that which has been well described in the placenta. There are two principal pathways of oxytocin degradation: aminopeptidase activity, found mainly in the cytosolic fractions, and post-proline Post-proline endopeptidase Fig. 3 . Metabolism of oxytocin. In uterine tissues, oxytocin is metabolised through two major pathways: aminopeptidase, where the ring structure is opened between Cys 1 and Tyr 2 and amino acids are serially cleaved from the amino terminus; and post-proline endopeptidase, which cleaves between the Pro 7 and Leu 8 amino acids.
endopeptidase activity, localized mainly in the microsomal fractions. Contrary to our hypothesis, we could detect no significant changes in any activity around the time of parturition. Our studies using rat uterine and placental tissues were remarkably similar. Although there was a statistically significant decline in oxytocinase activity through late rat gestation, this decrease was only approximately 25% and we concluded it was unlikely to be the major factor responsible for the marked increase in oxytocin seen in the rat uterus at this time.
Oxytocin prohormones
The initial translation product from the oxytocin gene is a long peptide that contains the oxytocin sequence and neurophysin I (Altstein and Gainer, 1988). These two peptides are connected by the tripeptide sequence Gly-Lys-Arg (G-K-R). During posttranslational processing, neurophysin I is cleaved and the linking tripeptide remains with oxytocin (Fig. 4) . The oxytocin-G-K-R is converted by a carboxypeptidase to oxytocin-G-K and oxytocin-G. The oxytocin-G is converted by α-amidating enzyme to mature amidated oxytocin. The peptides containing oxytocin plus amino acids from the linking tripeptide are referred to as carboxy-extended forms of oxytocin (OTX).
In the rat hypothalamus, the ability to process the initial translation product completely changes with late fetal and early neonatal development (Altstein and Gainer, 1988) . In fetal sheep plasma, the concentrations of OTX forms are 35-fold higher than oxytocin at two-thirds of the way through gestation (Morris et al., 1992) . However, by term, the concentration of OTX has decreased by one half and oxytocin has increased several-fold, suggesting a similar pattern of maturation as in the rat hypothalamus. The concentration of OTX forms still remains several-fold higher than that of oxytocin. In human umbilical plasma, a similar pattern of maturation is noted when comparing samples obtained at term but before onset of labour with samples obtained after the spontaneous onset of labour (Mueller-Heubach et al., 1995) . This study suggests that maturation of OTX forms to oxytocin in the fetus may be implicated in the process of parturition.
We have demonstrated the presence of high concentrations of OTX forms in rat uterine tissues (B. F. Mitchell, X. Fang and S. Wong, unpublished), and hypothesized that these OTX forms act as competitive antagonists to oxytocin and that parturition occurred when the ratio of mature oxytocin to OTX reached a critical level. Over the last 5 days of gestation in rats, there was an approximately tenfold increase in uterine OTX concentrations (Fig. 5) . Over this time, oxytocin concentrations also increased markedly. However, contrary to our hypothesis, the ratio of mature oxytocin to OTX decreased around the time of parturition. Further studies using strips of pregnant rat myometrium in a muscle bath preparation demonstrated that the OTX forms possess minimal oxytocic activity and require several orders of magnitude greater concentrations than that of oxytocin to elicit approximately half the maximal uterine response. Concentration-response curves for oxytocin were unchanged in the presence of OTX forms at one to two orders of magnitude higher concentrations. In keeping with these findings, the OTX forms compete poorly with oxytocin for binding to oxytocin receptors, requiring several orders of magnitude higher concentrations to displace the radiolabelled oxytocin The carboxy-extended forms of oxytocin (OTX) are present in uterine tissues in much higher concentrations than mature oxytocin. The concentrations of both oxytocin and OTX forms increase through late gestation. In contrast to our hypothesis, the ratio of oxytocin to OTX forms did not increase during this interval. , OT; , total OT + OTX; , OT:OT + OTX.
from rat uterine oxytocin binding sites. We concluded that the only role for the carboxy-extended forms of oxytocin was as a precursor pool for oxytocin synthesis.
Oxytocin antagonists
Many oxytocin antagonists have been synthesized by alteration or substitution of various amino acid residues in the oxytocin molecule (Sawyer et al., 1980; Pak et al., 1994) . In general, these modifications have involved addition of a side chain to the tyrosine at position 2, together with substitution for the amino acids at positions 4 and 8. This results in a wide variety of compounds with various degrees of antagonistic properties and various degrees of specificity for oxytocin and vasopressin receptors. There are conflicting reports concerning the ability of these agents to prevent or delay parturition. Certain oxytocin antagonists will block the uterotonic effect in rats while stimulating endometrial prostaglandin synthesis (Chen et al., 1994) . These antagonists apparently do not delay the onset but prolong the duration of labour, causing extensive perinatal mortality (Chan et al., 1991; Schellenberg, 1995) . Other antagonists cause prolonged gestation, perhaps because they block both sites of oxytocin action (Fejgin et al., 1994; Antonijevic et al., 1995) . Early clinical trials in women with preterm labour suggest that some of these antagonists may be useful (Akerlund et al., 1987; Goodwin et al., 1994) . In addition, non-peptide oxytocin antagonists that can be administered orally have been developed (Pettibone et al., 1989) . Much further research is required to ascertain the role of oxytocin antagonists in clinical practice.
Conclusions
Despite a renewed interest in research into the role of oxytocin in parturition, there remains a poor understanding of its importance. Recent development of an oxytocin knockout mouse has demonstrated that oxytocin is essential for nursing but is not required for parturition or reproductive behaviour in this species (Nishimori et al., 1996; Young et al, 1996) . There is no evidence concerning the presence of an intrauterine paracrine system within the mouse uterus, and the extent to which these findings apply to other species in which such a paracrine system is present is not known. The balance of evidence in humans does not support an important role for circulating oxytocin in the process of parturition. However, recent research suggests a possible key role for oxytocin synthesized within the pregnant uterus as part of a paracrine system that could regulate myometrial contractility. Interactions with prostaglandins and modulation by oestrogen and progesterone could be important components of this paracrine system. The development of oxytocin antagonists, as well as of other pharmacological agents that could influence this paracrine network, affords an opportunity to develop new strategies to treat or prevent preterm labour and its potentially expensive and tragic consequences.
